Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration
Zhaohui Huang1, Pushuai Wen, Ruirui Kong
1Wuxi Oncology Institute, the Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China; Department of Neurology, Center for Genetic Medicine, Lurie Cancer Center, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., Chicago, IL.
Abstract:
Originally discovered in neuronal guidance, the Slit-Robo pathway is emerging as an important player in human cancers. However, its involvement and mechanism in colorectal cancer (CRC) remains to be elucidated. Here, we report that Slit2 expression is reduced in CRC tissues compared with adjacent noncancerous tissues. Extensive promoter hypermethylation of the Slit2 gene has been observed in CRC cells, which provides a mechanistic explanation for the Slit2 downregulation in CRC. Functional studies showed that Slit2 inhibits CRC cell migration in a Robo-dependent manner. Robo-interacting ubiquitin-specific protease 33 (USP33) is required for the inhibitory function of Slit2 on CRC cell migration by deubiquitinating and stabilizing Robo1. USP33 expression is downregulated in CRC samples, and reduced USP33 mRNA levels are correlated with increased tumor grade, lymph node metastasis and poor patient survival. Taken together, our data reveal USP33 as a previously unknown tumor-suppressing gene for CRC by mediating the inhibitory function of Slit-Robo signaling on CRC cell migration. Our work suggests the potential value of USP33 as an independent prognostic marker of CRC.
Insights
Slit-Robo signaling, specifically Slit2 and USP33, suppresses colorectal cancer (CRC) cell migration. Reduced expression of these molecules in CRC tissues correlates with poor patient outcomes, highlighting USP33 as a potential prognostic marker.
Area of Science:
- Molecular oncology
- Cell signaling pathways
Background:
- The Slit-Robo pathway, initially identified in neuronal development, is increasingly recognized for its role in human cancers.
- The specific involvement and underlying mechanisms of the Slit-Robo pathway in colorectal cancer (CRC) require further investigation.
Purpose of the Study:
- To elucidate the role and mechanism of Slit-Robo signaling in colorectal cancer progression.
- To investigate the expression and function of Slit2 and USP33 in CRC.
Main Methods:
- Analysis of Slit2 gene expression and promoter methylation in CRC tissues and cells.
- Functional assays to assess the impact of Slit2 on CRC cell migration.
- Investigation of the interaction between Slit2, Robo1, and USP33.
- Correlation analysis of USP33 expression with clinicopathological features and patient survival.
Main Results:
- Slit2 expression is significantly reduced in CRC tissues, primarily due to promoter hypermethylation.
- Slit2 inhibits CRC cell migration via a Robo-dependent mechanism.
- Ubiquitin-specific protease 33 (USP33) is essential for Slit2's inhibitory effect by stabilizing Robo1.
- USP33 is downregulated in CRC, and its reduced expression correlates with advanced tumor grade, lymph node metastasis, and poorer patient survival.
Conclusions:
- USP33 acts as a novel tumor suppressor in CRC by mediating the anti-migratory function of Slit-Robo signaling.
- USP33 represents a potential independent prognostic biomarker for colorectal cancer patients.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cell Polarization by Rho Proteins
Cell Migration
Cell Migration
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

